Interference with intraepithelial TNF-α signaling inhibits CD8 + T-cell-mediated lung injury in influenza infection

Viral Immunology

Volumn 23, Issue 6, 2010, Pages 639-645

  Srikiatkhachorn, Anon ^a   Chintapalli, Jyothi ^b   Liu, Jun ^b   Jamaluddin, Mohammad ^c   Harrod, Kevin S ^d   Whitsett, Jeffrey A ^e   Enelow, Richard I ^f   Ramana, Chilakamarti V ^f  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d Lovelace Resp Research Institute   (Mexico)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA BINDING; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT INFECTION; SIGNAL TRANSDUCTION;

ADENOVIRUS E3 PROTEINS; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; CHEMOKINES; INFLUENZA A VIRUS; LUNG INJURY; MICE; MICE, INBRED BALB C; NF-KAPPA B; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650108661     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0076     Document Type: Article

References (46)

1. Aldridge JR Jr, Moseley CE, Boltz DA, et al.: TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci USA 2009; 106:5306-5311.
2. Bowick GC, Fennewald SM, Zhang L, et al.: Attenuated and lethal variants of Pichindé virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics. Viral Immunol 2009;22:457-462.
3. Buchweitz JP, Harkema, JR, and Kaminski N: Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol Pathol 2007;35:424-435.
4. Burgert HG, and Blusch JH: Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses. Virus Genes 2000;21:13-25.
5. Bruder D, Srikiatkhachorn A, and Enelow RI: Cellular immunity and lung injury in respiratory virus infection. Viral Immunol 2006;19:147-155.
6. Charo IF, and Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006;354:610-621.
7. Conti P, and DiGioacchino M: MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Astma Proc 2001;22:133-137.
8. Deshmane SL, Kremlev S, Amini S, and Sawaya BE: Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res 2009;29:313-326.
9. Dugo L, Collin M, and Thiemermann C: Glycogen synthase kinase 3b as a target for the therapy of shock and inflammation. Shock 2007;27:113-123.
10. Enelow RI, Stoler MH, Srikriatkhachorn A, Kerlakian C, Agersborg S, Whitsett JA, and Braciale TJ: A lung-specific neo-antigen elicits specific CD8\+ T cell tolerance with preserved CD4\+ T cell reactivity. Implications for immune-mediated lung disease. J Clin Invest 1996;98:914-922.
11. Enelow RI, Mohammed AZ, Stoler MH, Young JS, Lou YH, and Braciale TJ: Structural and functional consequences of alveolar cell recognition by CD8\+ T lymphocytes in experimental lung disease. J Clin Invest 1998;102:1653-1661.
12. Ghosh S, and Karin M: Missing pieces in the NF-kappa B puzzle. Cell 2002;109(Suppl):S81-S96.
13. Gooding LR, Sofola IO, Tollefson AE, Duerksen-Hughes P, and Wold WS: The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. J Immunol 1990;145:3080-3086.
14. Gong R, Ge Y, Chen S, et al.: Glycogen synthase kinase 3b; A novel marker and modulator of inflammatory injury in chronic renal allograft disease. Am J Transplant 2007;8:1852-1863.
15. Gong R, Rifai A, Ge Y, Chen S, and Dworkin LD: Hepato-cyte growth factor suppresses proinflammatory NF-kB activation through GSK3b inactivation in renal tubular epithelial cells. J Biol Chem 2008;283:7401-7410.
16. Harrod KS, Mounday AD, and Whitsett JA: Adenoviral E3-14.7K protein in LPS-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol 2000;278:L631-L639.
17. Herold S, von Wulffen W, Steinmueller M, et al.: Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol 2006;177:1817-1824.
18. \+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol 2008;18:275-308.
19. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, and Woodgett JR: Requirement for glycogen synthase kinase-3 beta in cell survival and NF-kappaB activation. Nature 2000;406:86-90.
20. Kohlmeier K, and Woodland D: Immunity to respiratory viruses. Annu Rev Immunol 2009;27:61-82.
21. La Gruta NL, Kedzierska K, Stambas J, and Doherty PC: A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007;85:85-92.
22. Lichtenstein DL, Toth KL, Doronin K, Tollefson AE, and Wold WS: Functional and mechanisms of action of the ad-enovirus E3 proteins. Intl Rev Immunol 2004;23:75-111.
23. Lin KL, Suzuki Y, Nakano H, Ramsburg E, and Gunn MD: CCR2\+ Monocyte-derived dendritic cells and exudates macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 2008;180:2562-2572.
24. Liu J, Zhao MQ, Xu L, Ramana CV, Declercq W, Vandena-beele P, and Enelow RI: Requirement for tumor necrosis factor-receptor 2 in alveolar chemokine expression depends upon the form of the ligand. Am J Respir Cell Mol Biol 2005;33:463-469.
25. Look DC, Roswit WT, Frick AG, Gris-Alevy Y, Dickhaus DM, Walter MJ, and Holtzman MJ: Direct suppression of Stat1 function during adenoviral infection. Immunity 1998; 9:871-880.
26. Morgan DJ, Liblau R, Scott B, et al.: CD8\+ T cell-mediated spontaneous diabetes in neonatal mice. J Immunol 1996;157: 978-983.
27. Nachtwey J, and Spencer JV: HCMV IL-10 suppresses cy-tokine expression in monocytes through inhibition of nuclear factor-kappaB. Viral Immunol 2008;21:477-482.
28. Perkins ND: Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 2006;25:6717-6730.
29. Ping D, Boekhoudt GH, Rogers EM, and Boss JM: Nuclear factor-kappaB p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte che-moattractant-1 gene. J Immunol 1999;162:727-734.
30. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, and Tumpey TM: H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macro-phages and neutrophils in the lungs of mice. PLoS Pathog 2008;4:e1000115.
31. Rahman MM, and McFadden G: Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog 2006; 2:e4.
32. \+ T cell recognition. J Interferon Cytokine Res 2006;26: 318-327.
33. Ramirez-Carrozzi VR, Braas D, Bhatt DM, et al.: A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodelling. Cell 2009;138: 114-128.
34. Roe CE, Sung SS, and Fu SM: Significant involvement of CCL2 (MCP-1) inflammatory disorders of the lung. Micro-circulation 2003;10:273-288.
35. Russell JH, and Ley TJ: Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002;20:323-370.
36. \+ T cells. Nature 1999;401:76-79.
37. Small BA, Dressel SA, Lawrence CW, Drake DR 3rd, Stoler MH, Enelow RI, and Braciale TJ: CD8\+ T cell-mediated injury in vivo progresses in the absence of effector T cells. J Exp Med 2001;194:1835-1846.
38. Sparer TE, Tripp RA, Dillehay DL, Hermiston TW, Wold WS, and Gooding LR: The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J Virol 1996;70:2431-2439.
39. Steinbrecher K, Wilson W III, Cogswell PC, and Baldwin AS: Glycogen synthase kinase-3b functions to specify gene-specific, NF-kB-dependent transcription. Mol Cell Biol 2005; 25:8444-8455.
40. Vallabhapurapu S, and Karin M: Regulation and function of NF-kB transcription factors in the immune system. Annu Rev Immunol 2009;27:693-733.
41. Viola A, and Luster AD: Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 2008;48:171-197.
42. Wiley JA, Cerwenka A, Harkema JR, Dutton RW, and Harmsen AG: Production of interferon-gamma by influenza hemagglutinin-specific CD8\+ effector T cells influences the development of pulmonary immunopathology. Am J Pathol 2001;158:119-130.
43. Xu L, Yoon, H, Zhao MQ, Liu J, Ramana CV, and Enelow RI: Cutting Edge: Pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8\+ T cells. J Immunol 2004;173:721-725.
44. Yoon K, Jung EJ, and Lee SY: TRAF6-mediated regulation of the PI3 kinase (PI3K)-Akt-GSK3-beta cascade is required for TNF-induced cell survival. Biochem Biophys Res Commun 2008;371:118-121.
45. Zhao MQ, Stoler MH, Liu AN, Wei B, Soguero C, Hahn YS, and Enelow RI: Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8\+ T cell recognition. J Clin Invest 2000;106:49-58.
46. Zhou J, Matsuoka M, Homer R, Cantor H, and Enelow RI: Cutting Edge: NKG2A engagement on effector antiviral CD8\+ T cells inhibits immunopathology in influenza infection. J Immunol 2008;180:25-29.